Float Short %

15.46

Margin Of Safety %

-16

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.12

EPS Last/This Y

EPS This/Next Y

0.14

Price

13.34

Target Price

25.25

Analyst Recom

1.8

Performance Q

14.03

Relative Volume

1.73

Beta

1.24

Ticker: DVAX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	DVAX	12.82	0.48	0.05	6094
2025-01-24	DVAX	12.74	0.40	0.00	5112
2025-01-27	DVAX	12.59	0.38	72.52	5312
2025-01-28	DVAX	12.94	0.77	1.72	6836
2025-01-29	DVAX	12.98	0.78	0.13	6881
2025-01-30	DVAX	13.02	0.76	0.00	7015
2025-01-31	DVAX	13.03	0.74	0.07	7101
2025-02-03	DVAX	12.94	0.74	0.00	7106
2025-02-04	DVAX	12.99	0.74	0.38	7137
2025-02-05	DVAX	13.15	0.74	0.18	7169
2025-02-06	DVAX	13.11	0.73	0.01	7217
2025-02-07	DVAX	13.17	0.73	0.26	7270
2025-02-10	DVAX	13.21	0.72	0.00	7294
2025-02-11	DVAX	12.69	0.71	0.18	7399
2025-02-12	DVAX	12.45	0.70	0.03	7474
2025-02-13	DVAX	12.69	0.69	0.14	7563
2025-02-14	DVAX	12.82	0.69	0.15	7596
2025-02-18	DVAX	12.93	0.69	0.00	7618
2025-02-19	DVAX	13.1	0.41	0.07	10731
2025-02-20	DVAX	13.34	0.41	0.67	10821
2025-02-21	DVAX	13.34	0.41	2.06	10891
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	DVAX	12.80	0.0	-	0.20
2025-01-24	DVAX	12.74	0.0	-	0.20
2025-01-27	DVAX	12.58	0.0	-	0.20
2025-01-28	DVAX	12.94	0.0	-	0.20
2025-01-29	DVAX	12.97	0.0	-	0.20
2025-01-30	DVAX	13.01	0.0	-	0.20
2025-01-31	DVAX	13.03	0.0	-	0.20
2025-02-03	DVAX	12.94	0.0	-	0.20
2025-02-04	DVAX	12.98	0.0	-	0.20
2025-02-05	DVAX	13.15	0.0	-	0.20
2025-02-06	DVAX	13.12	0.0	-	0.20
2025-02-07	DVAX	13.17	0.0	-	0.20
2025-02-10	DVAX	13.20	0.0	-	0.20
2025-02-11	DVAX	12.69	0.0	-	0.20
2025-02-12	DVAX	12.45	0.0	-	0.20
2025-02-13	DVAX	12.69	0.0	-	0.20
2025-02-14	DVAX	12.82	0.0	-	0.20
2025-02-18	DVAX	12.93	0.0	-	0.20
2025-02-19	DVAX	13.09	0.0	-	0.20
2025-02-20	DVAX	13.34	0.0	-	0.20
2025-02-21	DVAX	13.34	0.0	-	0.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	DVAX	0.00	-0.28	13.09
2025-01-24	DVAX	0.00	-0.28	13.09
2025-01-27	DVAX	0.00	-0.27	13.09
2025-01-28	DVAX	0.00	-0.27	14.64
2025-01-29	DVAX	0.00	-0.27	14.64
2025-01-30	DVAX	0.00	-0.27	14.64
2025-01-31	DVAX	0.00	-0.27	14.64
2025-02-03	DVAX	0.00	-0.35	14.64
2025-02-04	DVAX	0.00	-0.35	14.64
2025-02-05	DVAX	0.00	-0.35	14.64
2025-02-06	DVAX	0.00	-0.35	14.64
2025-02-07	DVAX	0.00	-0.35	14.64
2025-02-10	DVAX	0.00	-0.55	14.64
2025-02-11	DVAX	0.00	-0.55	14.64
2025-02-12	DVAX	0.00	-0.55	14.85
2025-02-13	DVAX	0.00	-0.55	14.85
2025-02-14	DVAX	0.00	-0.55	14.85
2025-02-18	DVAX	0.00	0.71	14.85
2025-02-19	DVAX	0.00	0.71	15.46
2025-02-20	DVAX	0.00	0.71	15.46
2025-02-21	DVAX	0.00	0.71	15.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.12

Avg. EPS Est. Current Quarter

0.04

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

Institutional Transactions

0.71

Beta

1.24

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

11.17

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

37.6

Max Drawdown 5-Year %

-68.1

Target Price

25.25

P/E

102.3

Forward P/E

23.14

PEG

1.85

P/S

6.72

P/B

2.57

P/Free Cash Flow

77.3

EPS

0.13

Average EPS Est. Cur. Y

0.2

EPS Next Y. (Est.)

0.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.85

Relative Volume

1.73

Return on Equity vs Sector %

-16.2

Return on Equity vs Industry %

-4.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

Dynavax Technologies Corporatio

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 405

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

stock quote shares DVAX – Dynavax Technologies Corporation Stock Price stock today

news today DVAX – Dynavax Technologies Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch DVAX – Dynavax Technologies Corporation yahoo finance google finance

stock history DVAX – Dynavax Technologies Corporation invest stock market

stock prices DVAX premarket after hours

ticker DVAX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y